495 related articles for article (PubMed ID: 12209972)
21. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis.
Yin G; Liu W; An P; Li P; Ding I; Planelles V; Schwarz EM; Min W
Mol Ther; 2002 May; 5(5 Pt 1):547-54. PubMed ID: 11991745
[TBL] [Abstract][Full Text] [Related]
22. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
Philipp W; Speicher L; Humpel C
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
[TBL] [Abstract][Full Text] [Related]
23. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes.
Ergün S; Kilic N; Wurmbach JH; Ebrahimnejad A; Fernando M; Sevinc S; Kilic E; Chalajour F; Fiedler W; Lauke H; Lamszus K; Hammerer P; Weil J; Herbst H; Folkman J
Angiogenesis; 2001; 4(3):193-206. PubMed ID: 11911017
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
Maruyama K; Mori Y; Murasawa S; Masaki H; Takahashi N; Tsutusmi Y; Moriguchi Y; Shibazaki Y; Tanaka Y; Shibuya M; Inada M; Matsubara H; Iwasaka T
J Mol Cell Cardiol; 1999 Mar; 31(3):607-17. PubMed ID: 10198191
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
Hoshino M; Nakamura Y; Hamid QA
J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
27. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK
Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
Wood JM
Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
[TBL] [Abstract][Full Text] [Related]
29. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
[TBL] [Abstract][Full Text] [Related]
30. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
31. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain.
Krum JM; Mani N; Rosenstein JM
Neuroscience; 2002; 110(4):589-604. PubMed ID: 11934468
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
33. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
34. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis.
Li J; Brown LF; Hibberd MG; Grossman JD; Morgan JP; Simons M
Am J Physiol; 1996 May; 270(5 Pt 2):H1803-11. PubMed ID: 8928889
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
[TBL] [Abstract][Full Text] [Related]
36. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
[TBL] [Abstract][Full Text] [Related]
37. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas.
Detmar M; Velasco P; Richard L; Claffey KP; Streit M; Riccardi L; Skobe M; Brown LF
Am J Pathol; 2000 Jan; 156(1):159-67. PubMed ID: 10623663
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
40. Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.
Vajkoczy P; Thurnher A; Hirth KP; Schilling L; Schmiedek P; Ullrich A; Menger MD
Oncologist; 2000; 5 Suppl 1():16-9. PubMed ID: 10804086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
